THNR
Amplify Weight Loss Drug & Treatment ETF
1W: -0.0%
1M: -8.1%
3M: -6.4%
YTD: -6.0%
1Y: +7.7%
$23.67
+0.00 (+0.00%)
After Hours: $25.86 (+2.19, +9.27%)
Overview
Chart
Holdings
Changes
Technicals
Analysis
Peers
Institutions
Dark Pool
Short Interest
Weather
ETF-Level Metrics
AUM$3M
Holdings22
Top 10 Wt68.8%
Beta0.54
% Profitable64%
Coverage90%
Portfolio Valuation
P/E23.9
P/B5.3
P/S7.3
EV/EBITDA17.4
P/FCF32.0
PEG1.14
Profitability & Returns
Gross Margin77.1%
Net Margin30.7%
ROE23.1%
ROA15.6%
ROIC27.4%
Div Yield2.18%
Leverage & Liquidity
Debt/Equity0.16
Debt/Assets0.11
Net Debt/EBITDA-0.6x
Interest Cov34.6x
Current Ratio2.66
Quick Ratio2.21
Growth (YoY)
Revenue+28.0%
Net Income+35.2%
EPS+46.0%
FCF+32.7%
EBITDA+36.6%
Rev CAGR 3Y+35.0%
Quality Scores
Piotroski F6.0
Altman Z7.65
IS Quality76.3
IS Overall66.2
IS Value53.8
Median P/E23.5
Sector Breakdown
3 sectors| Sector | # Holdings | Total Weight % | Avg P/E |
|---|---|---|---|
| Healthcare | 19 | 97.2% | 24.1 |
| Financial Services | 1 | 1.5% | — |
| Other | 2 | 1.3% | — |
Smart Money Overlap
3 holdings with signals
Showing 22 of 22 holdings
· Page 1 of 1
| # | Name | Ticker | Weight % ▼ | Mkt Value | Shares | P/E | Mkt Cap | Sector |
|---|---|---|---|---|---|---|---|---|
| 1 | Novo Nordisk A/S | NVO | 12.12% | $488,888 | 13,431 | 9.9 | $160.2B | Healthcare |
| 2 | Eli Lilly & Co | LLY | 11.61% | $468,234 | 522 | 38.2 | $829.8B | Healthcare |
| 3 | Regeneron Pharmaceuticals Inc | REGN | 6.83% | $275,450 | 364 | 16.9 | $76.7B | Healthcare |
| 4 | Amgen Inc | AMGN | 6.48% | $261,338 | 740 | 24.4 | $188.0B | Healthcare |
| 5 | Chugai Pharmaceutical Co Ltd | 4519.T | 6.04% | $243,476 | 4,600 | 32.4 | $14.1T | Healthcare |
| 6 | Merck & Co Inc | MRK | 5.20% | $209,674 | 1,763 | 16.3 | $295.8B | Healthcare |
| 7 | Pfizer Inc | PFE | 5.20% | $209,697 | 7,606 | 19.8 | $153.7B | Healthcare |
| 8 | Arrowhead Pharmaceuticals Inc | ARWR | 4.95% | $199,751 | 3,287 | 40.0 | $8.1B | Healthcare |
| 9 | Shionogi & Co Ltd | 4507.T | 4.94% | $199,195 | 9,200 | 15.4 | $3.0T | Healthcare |
| 10 | Roche Holding AG | ROP.SW | 4.92% | $198,272 | 503 | — | $248.7B | Healthcare |
| 11 | Innovent Biologics Inc | 1801.HK | 4.91% | $197,861 | 19,500 | 84.3 | $147.1B | Healthcare |
| 12 | AstraZeneca PLC | AZN | 4.83% | $194,954 | 1,063 | 28.4 | $146.1B | Healthcare |
| 13 | AbbVie Inc | ABBV | 4.75% | $191,486 | 907 | 88.2 | $370.2B | Healthcare |
| 14 | CSPC Pharmaceutical Group Ltd | 1093.HK | 4.65% | $187,701 | 180,000 | 25.5 | $106.1B | Healthcare |
| 15 | Viking Therapeutics Inc | VKTX | 2.39% | $96,516 | 2,818 | -10.3 | $3.8B | Healthcare |
| 16 | Scholar Rock Holding Corp | SRRK | 2.20% | $88,641 | 2,005 | -12.9 | $4.9B | Healthcare |
| 17 | Structure Therapeutics Inc | GPCR | 1.99% | $80,296 | 1,738 | -19.3 | $2.6B | Healthcare |
| 18 | Zealand Pharma A/S | ZEAL.CO | 1.75% | $70,433 | 1,584 | 3.2 | $20.3B | Healthcare |
| 19 | Invesco Government & Agency Portfolio 12/31/2031 | AGPXX | 1.48% | $59,798 | 59,798 | — | $79.1B | Financial Services |
| 20 | Hanmi Pharm Co Ltd | 128940.KS | 1.43% | $57,782 | 158 | 34.2 | $7.0T | Healthcare |
| 21 | Jiangsu Hengrui Pharmaceuticals Co Ltd Private | 1276.HK | 1.20% | $48,529 | 6,200 | — | — | — |
| 22 | Cash & Other Cash | 0.14% | $5,575 | 5,575 | — | — | — |